Foreign institutional investors (FIIs) turned net buyers in select stocks during the September 2026 quarter after reducing their exposure for two consecutive quarters. They increased their stakes in 125 stocks with a market capitalisation of over Rs 2,500 crore, following periods of reduced exposure in the December 2025–March 2026 and March–June 2026 quarters.
In terms of stock performance, around 15 of these stocks delivered double-digit price returns over the past three months. Among them, the top eight gainers recorded returns ranging from 20% to 135% during the period. (Data Source: ACE Equity)
Morepen Laboratories shares surged 135% over the past three months, rising from Rs 52 to Rs 123. FIIs increased their stake to 3.43% in the September 2026 quarter from 1.46% in June 2026. Their holdings stood at 1.62% in December 2025 and 1.58% in March 2026 before declining to 1.46% in June.
Shanti Gold International shares gained 77% over the past three months, climbing from Rs 207 to Rs 368. FIIs raised their stake to 2.22% in the September 2026 quarter from 1.92% in June 2026. Their holdings were 2.21% in December 2025 and 2.18% in March 2026.
Ind-Swift Laboratories shares advanced 45% over the past three months, moving from Rs 225 to Rs 328. FII holdings edged up to 10.78% in the September 2026 quarter from 10.70% in June. However, their stake had declined from 14.33% in December 2025 to 13.88% in March 2026 and 10.70% in June 2026.